Equity Lunch Research 24 March 2021
View PDF
24 Mar 2021

Market Review (Session 1)

In session 1, JCI closed with negative 0.91% at level of 6,195.94


Market Prediction (Session 2)

JCI: In accordance with our prediction, at the beginning JCI will weaken towards the support flow. JCI is still moving in the range of our support flow. If JCI holds, there is potential to strengthen up to the nearest resistance at level of6,268. If JCI can't hold above support level, it can continue the downward trend..

• BWPT: The price is corrected and has gone down below the support level. The price seem to fail to sustain the potential upside. We suggest to be careful if the next candle does not return above the support, the price can continue to fall to the next support at the range of 108 - 111.

• LPPF: The price only touches the first target at 1,505 and the highest at 1,510 (+2.37%). We suggest to be careful if the price does not return above level 1,480 or closed in bearish candle. If the next candle the price below support, it can continue to fall to the next support at 1,355.

• TOWR: The price is still in our buy range and still have the opportunity to strengthen as long as it maintain above the support level in the near future (approx. 1-2 candles). If it can't hold above support level, we suggest to wait at the next support at 1,040 for entry buy.

• UNVR: The price is still in our buy range and still has the opportunity to strengthen as long as there is it stay above support level in the near future (approx. 1-2 candles). If the price gone down below support levrl, we suggest may watch for the next support level of 6,475 (May buy if the price can hold above level 6,475 or be careful if the price breaks down to below that level because the downtrend will continue in the near future)


News

• PT Chitose Internasional Tbk (CINT) experienced a decline in financial performance throughout 2020. CINT's net sales were recorded at Rp. 330.67 billion by the end of 2020. This number decreased by 18.84% (yoy) compared to CINT's net sales realization in 2019 of Rp. 407.45 billion.

• PT Diagnos Laboratorium Utama Tbk (DGNS) managed to book a net profit of Rp 52 billion in 2020 or grew 468% from the previous year which amounted to Rp 9.2 billion per year, in terms of revenue DGNS managed to book Rp 183 billion or growth of 256.8 % from the previous year which amounted to Rp 51.3 billion.




PT Kiwoom Sekuritas Indonesia (KSI)

Treasury Tower 27th Floor Unit A, District 8 Kawasan SCBD Lot 28

Jl.Jend.Sudirman Kav 52-53, Jakarta Selatan 12190

Telp : +62 21 5010 5800

Fax. +62 21 5010 5820

Website : www.kiwoom.co.id